Noqturina (Desmopressin)

Desmopressin, the active ingredient in Noqturina, is a vasopressin analog presented as a sublingual formulation for sublingual use. It is used to manage central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders such as hemophilia A and von Willebrand disease.

GNH USA supplies Noqturina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to reduce urine output and increase coagulation factor levels. - Central diabetes insipidus: reduces excessive urine production and stabilizes fluid balance. - Nocturnal enuresis: decreases nighttime bladder emptying episodes in children and adults. - Hemophilia A: raises plasma factor VIII levels to improve clotting. - von Willebrand disease: elevates von Willebrand factor to enhance platelet adhesion.

Desmopressin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head. - Nasal congestion: feeling of a blocked nose. - Nausea: upset stomach or urge to vomit. - Hyponatremia: low blood sodium, usually mild.

Serious or Rare Side Effects: - Severe hyponatremia with seizures: dangerous drop in sodium causing neurological symptoms. - Thrombotic events: blood clot formation in veins or arteries. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Water intoxication: excessive water retention leading to swelling.

Before initiating therapy, clinicians should consider several safety measures. - Assess fluid balance: monitor urine output and body weight regularly. - Check serum sodium: evaluate electrolytes before initiating therapy and during treatment. - Limit fluid intake: advise patients to restrict excessive water consumption while on medication. - Use with caution in renal impairment: adjust monitoring for patients with reduced kidney function. - Avoid in uncontrolled hypertension: evaluate blood pressure before prescribing. - Store at room temperature: keep below 25°C in the original packaging, protect from moisture.

Desmopressin can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Concomitant use of thiazide diuretics: may potentiate hyponatremia. - NSAIDs (e.g., ibuprofen, naproxen): increase risk of water retention and low sodium. - Antidepressants that affect serotonin (e.g., SSRIs): can exacerbate hyponatremia.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): desmopressin may affect bleeding risk. - CYP450 substrates: although desmopressin is not metabolized extensively, monitor for unexpected effects. - Alcohol: may enhance central nervous system effects and fluid balance changes.